Conor McNamara
Stock Analyst at RBC Capital
(0.86)
# 3,771
Out of 4,935 analysts
134
Total ratings
23.23%
Success rate
-18.59%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $251 → $255 | $151.95 | +67.82% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.97 | +52.28% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $40.99 | +12.22% | 1 | Aug 7, 2025 | |
| TECH Bio-Techne | Maintains: Sector Perform | $63 → $61 | $50.42 | +20.98% | 10 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $68.06 | +27.83% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $11.50 | +47.83% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $94.56 | +33.25% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $264.21 | +54.80% | 12 | Aug 1, 2025 | |
| RGEN Repligen | Maintains: Outperform | $193 → $204 | $111.43 | +83.07% | 12 | Jul 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $247.05 | +58.67% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $460.72 | +38.26% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $200.56 | +24.65% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $23.91 | +155.12% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.20 | +490.91% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.18 | +120.13% | 4 | Aug 7, 2024 |
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $151.95
Upside: +67.82%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.97
Upside: +52.28%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $40.99
Upside: +12.22%
Bio-Techne
Aug 7, 2025
Maintains: Sector Perform
Price Target: $63 → $61
Current: $50.42
Upside: +20.98%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $68.06
Upside: +27.83%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.50
Upside: +47.83%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $94.56
Upside: +33.25%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $264.21
Upside: +54.80%
Repligen
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $111.43
Upside: +83.07%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $247.05
Upside: +58.67%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $460.72
Upside: +38.26%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $200.56
Upside: +24.65%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $23.91
Upside: +155.12%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.20
Upside: +490.91%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.18
Upside: +120.13%